bearish
Beijing Airdoc Technology (2251.HK) - Not Optimistic About Turning Loss into Profit
309 Views21 Jun 2022 08:42
Without entering NRDL and public hospital markets, Airdoc’s products are hard to generate good performance due to high pricing but limited value. We are not optimistic Airdoc can turn loss into profit
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
x